C Partners Holding Gmb H Myriad Genetics Inc Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$27.23 - $45.56 $74,174 - $124,105	-2,724 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $181,350 - $242,991	-4,827 Reduced 63.93%	2,724 $125,000
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $41,930 - $60,696	1,511 Added 25.02%	7,551 $282,000
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $46,560 - $66,231	-1,615 Reduced 21.1%	6,040 $178,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $217,784 - $284,306	7,655	7,655 $263,000

191

94.2M

280K

14.3K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.